Integra Lifesciences Holdings (IART) Current Taxes (2021 - 2026)

Integra Lifesciences Holdings (IART) posted Current Taxes of $3.2 million for Q2 2026, little changed sequentially from $3.2 million in Q1 2026.

Integra Lifesciences Holdings (IART) Current Taxes (2021 - 2026) Analysis & Trends

Integra Lifesciences Holdings has reported Current Taxes for 3 years, with the latest figure at $3.2 million in Q2 2026.

Quarterly Current Taxes changed N/A year-over-year to $3.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, changed N/A from the prior year.
Current Taxes steadied at $3.2 million in Q2 2026 per IART's latest filing, from $3.2 million in the prior quarter.
Over five years, Current Taxes peaked at $3.7 million in Q4 2025 and troughed at $3.2 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	411.00 Mn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	224.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	914.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	195.28 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	86.50 Mn
10	Integra Lifesciences Holdings	1.28 Bn	1.01 Bn	219.74 Mn	3.24 Mn

Download Data